abstract |
The subject of the invention is new derivatives of 2-arylimino-2, 3-dihydrothiazoles, their methods of preparation and their use as medicaments, in particular in the treatment of pathological states or diseases in which one (or more) somatostatin receptor is (are) involved. These conditions include in particular acromegaly, pituitary adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome, and gastrointestinal bleeding. |